Prediction of Moxifloxacin Concentrations in Tuberculosis Patient Populations by Physiologically Based Pharmacokinetic Modeling-Reference-Cited by-同舟云学术

Prediction of Moxifloxacin Concentrations in Tuberculosis Patient Populations by Physiologically Based Pharmacokinetic Modeling

Published:2021-10-25 Issue: Volume: Page:
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Litjens Carlijn H. C.¹²^ORCID,Verscheijden Laurens F. M.²,Bolwerk Celine¹,Greupink Rick²,Koenderink Jan B.²,den Broek Petra H. H.²,den Heuvel Jeroen J. M. W.²,Svensson Elin M.¹³,Boeree Martin J.⁴,Magis‐Escurra Cecile⁴,Hoefsloot Wouter⁴,Crevel Reinout⁵,Laarhoven Arjan⁵,Ingen Jakko⁶,Kuipers Saskia⁶,Ruslami Rovina⁷⁸,Burger David M.¹,Russel Frans G. M.²,Aarnoutse Rob E.¹,te Brake Lindsey H. M.¹

Affiliation:

1. Department of Pharmacy Radboud Institute for Health Sciences & Radboudumc Center for Infectious Diseases Radboud University Medical Center Nijmegen The Netherlands

2. Department of Pharmacology and Toxicology Radboud Institute for Molecular Life Sciences, Radboud University Medical Center Nijmegen The Netherlands

3. Department of Pharmaceutical Biosciences Uppsala University Uppsala Sweden

4. Department of Pulmonary Diseases Radboud Institute for Health Sciences & Radboudumc Center for Infectious Diseases Radboud University Medical Center Nijmegen The Netherlands

5. Department of Internal Medicine Radboud Institute for Health Sciences & Radboudumc Center for Infectious Diseases Radboud University Medical Center Nijmegen The Netherlands

6. Department of Medical Microbiology Radboud Institute for Health Sciences & Radboudumc Center for Infectious Diseases Radboud University Medical Center Nijmegen The Netherlands

7. TB/HIV Research Centre Faculty of Medicine Universitas Padjadjaran Bandung Indonesia

8. Department of Biomedical Sciences Division of Pharmacology and Therapy Faculty of Medicine Universitas Padjadjaran Bandung Indonesia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1972

Reference50 articles.

1. WHO.Global tuberculosis report 2019.https://www.who.int/tb/publications/global_report/en/. Accessed December 11 2019.

2. Moxifloxacin safety: an analysis of 14 years of clinical data;Tulkens PM;Drugs R D,2012

3. Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre‐optic bronchoscopy;Soman A;J Antimicrob Chemother,1999

4. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open‐label, randomised controlled phase 2 trial;Ruslami R;Lancet Infect Dis,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extrapolation of lung pharmacokinetics of antitubercular drugs from preclinical species to humans using PBPK modelling;Journal of Antimicrobial Chemotherapy;2024-04-10

2. QSPR analysis of distance-based structural indices for drug compounds in tuberculosis treatment;Heliyon;2024-01

3. Current Insights into Diagnosing and Treating Neurotuberculosis in Adults;CNS Drugs;2023-11

4. A hybrid framework of artificial intelligence-based neural network model (ANN) and central composite design (CCD) in quality by design formulation development of orodispersible moxifloxacin tablets: Physicochemical evaluation, compaction analysis, and its in-silico PBPK modeling;Journal of Drug Delivery Science and Technology;2023-04

5. Clinical standards for the dosing and management of TB drugs;The International Journal of Tuberculosis and Lung Disease;2022-06-01